Demyelinating Neurological Disorders Program A preclinical off-the-shelf cell-therapy program targeting demyelinating neurological diseases, including multiple sclerosis, with a development candidate planned for 2026.
Visit productCosigns Received
Be the first Cosign
Put your name behind Demyelinating Neurological Disorders Program.
Add it to your Products I use list and share why you use it.